Best Life Sciences Tech Companies in Australia
The 61 best Life Sciences Tech companies in Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Novotech.
Here's the thing about Life Sciences Tech in Australia right now: 61 companies, $302M in disclosed funding, and one unicorn already on the board. That's a market worth mapping carefully, and this directory does exactly that, ranking the best Life Sciences Tech companies in Australia by disclosed equity funding and recent momentum.
Novotech dominates the field at $255M, which is honestly most of the room. HealthMatch follows at $28M, Bluechiip at $12M, and the rest of the pack clusters well below that. So you've got a classic power-law stack here. One outlier pulling the headline number, a thin middle tier, and a long tail of early-stage bets. Backers like Artesian and Melbourne Angels are clearly comfortable operating in that tail. According to 2020 research, the structural case for life sciences investment keeps strengthening as regulatory compliance and intellectual property protection become harder to navigate without dedicated tech. Can the mid-tier companies close that funding gap? That's the question this cohort needs to answer fast. Median app install growth across healthcare and life sciences platforms is running at roughly 43% year-over-year, which tells you demand is real and building. The sector's live. Watch it.
- EVERSANA
- LifeSciencesIntelligence
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Australia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Novotech 🦄 Provider of clinical research services across all trial phases and therapeutic areas 72Funding top 25%Fin. health top 26%Product top 26%Innovation top 34% All 10 signals ▾Fundingtop 25% Fin. healthtop 26% Producttop 26% Innovationtop 34% Markettop 36% Techtop 37% Moattop 37% Growthbottom 46% Globalbottom 39% Newsbottom 34% Funding: Raised $255M across 2 rounds · 2 rounds over 13 yrs (0.2/yr) Fin. health: Revenue ~$336M · Revenue +4% YoY rank vs industry peers · Fliar Intelligence Index 72/100 | $255M | 15 mo ago | Acquired | — | 2002 | DrupalApple iCloud MailMicrosoft 365+28 | 1 partnership |
| 2 | HealthMatch Provider of patient recruitment platform 62Tech top 24%Funding top 38%Growth top 45%AI top 45% All 7 signals ▾Techtop 24% Fundingtop 38% Growthtop 45% AItop 45% Marketbottom 44% Globalbottom 37% Newsbottom 22% Tech: 32 technologies across 7/8 capability areas · Cloud: Amazon Alb, Amazon Cloudfront Funding: Raised $27.5M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 62/100 | $28M | 45 mo ago | Series C | — | 2016 | Google Sign-inMUIReact+13 | — |
| 3 | Bluechiip Wireless tracking solutions for bio samples and other products 27Moat top 32%Patents top 36%Funding top 42%Global top 45% All 8 signals ▾Moattop 32% Patentstop 36% Fundingtop 42% Globaltop 45% Innovationtop 47% Newsbottom 36% Marketbottom 33% Techbottom 32% Moat: Editorial + unicorn rating 5/10 · IP moat: 31 patents Patents: 31 patents matched (strict assignee match) · 9 filings since 2022 vs 17 in 2017-21 rank vs industry peers · Fliar Intelligence Index 27/100 | $12M | 38 mo ago | Public | — | 2003 | — | 1 launch · 1 partnership |
| 4 | Evrima Evrima Technologies expedites the clinical trial process by enabling the discovery and registration of active… | $3M | 46 mo ago | Seed | Charlotte Bradshaw Founder & CEO | 2018 | HubSpot CMS HubEnvoycore-js+17 | — |
| 5 | Mass Dynamics Provider of platform for proteomics and discovery scientists | $2M | 61 mo ago | Seed | Aaron Triantafyllidis Co-Founder | 2015 | — | 1 launch |
| 6 | H3D Provider of software to manufacturers and labs custom-fit businesses 37Tech top 28%Growth top 35%Funding top 46%Moat top 48% All 7 signals ▾Techtop 28% Growthtop 35% Fundingtop 46% Moattop 48% Talentbottom 49% Globalbottom 29% Marketbottom 23% Tech: 55 technologies across 4/8 capability areas · Cloud: Amazon Web Services, Cloudflare Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 37/100 | $1M | 9 mo ago | Series A | Phil Kinsella Founder & CTO | 2018 | WordPress Block EditorElementorWordPress+38 | 1 partnership |
| 7 | Aurabox Cloud-based medical imaging storage and viewing platform | $500K | 50 mo ago | Seed | ⭐️ Christopher Skene Co-Founder/CTO/Head of Magic | 2021 | — | — |
| 8 | Covidence Manufacturer of prefabricated housing and building materials | $500K | 97 mo ago | Funding Raised | Julian Elliott CEO | 2014 | SentryAtlassian StatuspageTypeScript+35 | — |
| 9 | Neoclinical Enabling patient recruitment through a searchable registry of clinical trials | $466K | 132 mo ago | Seed | Geoff Denman Co-Founder & CEO | 2008 | — | — |
| 10 | ComWriter Academic writing platform | $250K | 167 mo ago | Seed | Linda Glassop Founder & CEO | 2012 | — | — |
Top 11 Life Sciences Tech companies in Australia
#1
Novotech 🦄Acquired · Sydney, New South Wales · founded 2002 · 51 employees$255Mraised▾
Provider of clinical research services across all trial phases and therapeutic areas. It offers services including medical and regulatory consulting, patient recruitment, site selection, early phase trials, clinical operations, project management, site management, biometrics, data management, virtual clinical trials, real-world data analysis, and laboratory services. It also provides specialized services for oncology, pharmacometrics, drug development consulting, GMO solutions, liver disease, infectious diseases, vaccines, and orphan/rare diseases. It focuses on clinical and regulatory strategy to assist biotechnology companies in conducting early-phase clinical trials.
- Mar 2025Seed—
- Jan 2022Conventional Debt$505M
- Jan 2022PE$255M
- Feb 2021PE—
#2
Series A · Melbourne, Victoria · founded 2018 · 11 employees$1Mraised▾
Provider of software to manufacturers and labs custom-fit businesses. The company offer products such as dental autodesign, audio autodesign, and smartphone scanning. It allows manufacturers to create custom-fit hearing devices without needing impression material or expensive 3D scanning technology.
- Sep 2025Series A$5.8M
- Aug 2021Seed$1M
- Grant (prize money)$200K
#3
Public · Scoresby, Victoria · founded 2003 · 11 employees$11.9Mraised▾
Bluechiip provides wireless tracking solutions for bio samples and other products. It has an IT‑based temperature and identification tracking solution. It has embedded solutions for oem partners for the complete supply chain tracking solution. Products include retrofit buttons, multi-vial reader, hand-held reader, smart chip, cryovials, cassettes, racks / frames & towers, cryotag, matchbox reader & retriever and Stream software for web-based sample management and temperature chain-of-custody application for biosamples stored in cryogenic environments. Listed on ASX in 2011.
- May 2023Post IPO$1.5M
- Sep 2018Post IPO$5.5M
- Jun 2017Post IPO$3.4M
- Sep 2016Post IPO$1.5M
#4
Series C · Surry Hills, New South Wales · founded 2016 · 31 employees$27.5Mraised▾
HealthMatch provides a patient recruitment platform. The platform provides patients access to clinical trials from a network of care teams around the world. The company uses artificial intelligence to clinical data, by which patients are matched in real-time to clinical trials tailored to their medical profile.
- Sep 2022Series C$6.8M
- Dec 2020Series B$13.4M
- Nov 2019Series A$6M
- Jun 2018Seed$1.3M
#5
Seed · Sydney, New South Wales · founded 2018 · 24 employees$3Mraised▾
Evrima is a company that specializes in enabling and expediting the clinical trial process. They offer a platform for discovering and registering for active clinical trials and medical research.
- Sep 2022Seed$3M
#6
Seed · Melbourne, Victoria · founded 2015 · 16 employees$1.5Mraised▾
Mass Dynamics provides mass spectrometry software for proteomics and discovery scientists. MD Discovery creates insights into disease mechanisms, discovers new drugs, or identifies changes in protein levels from a set of designed experiments. MD Targeted is a service made to allows drug products to be characterized.
- May 2021Seed$1.5M
#7
Seed · Canberra, Australian Capital Territory · founded 2021 · 5 employees$500Kraised▾
Cloud-based medical imaging storage and viewing platform. The company has developed software that assists with disease diagnosis. It has features for uploading images, patient record management, storage, and more.
- May 2022Angel$500K
#8
Funding Raised · Melbourne, Victoria · founded 2014$500Kraised▾
Manufacturer of prefabricated housing and building materials. It designs and constructs budget-friendly precast housing solutions, utilizing innovative technologies. The company also manufactures off-site building materials, including SpaceSaver Panels and Interlocking Hollow Blocks, designed for eco-friendly and swift construction. Services include design, construction, and project management for various structures, ranging from single rooms to larger communal buildings such as schools and training facilities. Payment options include cash and financing partnerships.
- May 2018Grant (prize money)$500K
#9
Seed · Sydney, New South Wales · founded 2008 · 11 employees$465.7Kraised▾
Neoclinical enables patient recruitment by providing a searchable registry of clinical trials. Clinics, biopharma companies and other institutions can post their trials on the platform free of cost. Patients and their heathcare providers can search for the platform to find ongoing clinical trials for their specific condition. The company has received funding from Carthona Capital.
- 2015Seed—
- Aug 2014Seed$465.7K
#10
Seed · Buderim, Queensland · founded 2012$250Kraised▾
ComWriter is a writing platform for academic writing. Features include referencing from over 2 million resources on the platform or creating personal references from the web. Provides auto formatting, background templates, and outlines for writing. Also provides a dashboard for tracking all of the projects in the same place. Has different output styles and header and footer options for professional writing. Help in collaborating with others and inviting people to review the work.
- Aug 2012Seed$250K
#11
Seed · Adelaide, South Australia · founded 2010 · 5 employees—raised▾
goACT is a mobile and web-based platform for clinical trial enrollment. It helps health researchers to recruit the patients for their clinical trials or studies by matching them with the people visiting their website and/or their advertisement. It also provides researchers, a platform to manage their study and engage with their enrolled patients.
- 2013Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Australia
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 861 Australia-affiliated papers.
- University College London67
- The University of Queensland63
- The University of Melbourne59
- Agriculture and Food54
- La Trobe University35
- Mutant2→11
- Genome1→7
- Immune system1→5
- Antibody1→4
- Mitochondrion2→4
- Gene5→17
- Immune system2→13
- Antibody1→10
- Messenger RNA1→10
- Mutant1→9
- Agriculture5→19
- Sustainability3→8
- Emerging technologies1→4
- Resistance (ecology)3→6
- Bacteria2→5
Where biotechnology is researched across Australia
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.